Lowest Price Guaranteed From USD 5,899
Published
September 2021
Pages
237
View Count
6118
Example Insights
 |
 |
 |
 |
 |
 |
 |
Report Description
Over the past few decades, biopharmaceuticals have gained significant popularity owing to their therapeutic efficacy, favorable safety profiles and ability to treat a wide variety of disease indications, which are otherwise hard to treat. The success of these interventions has prompted the stakeholders to upgrade the conventional biologics manufacturing equipment. As a result, the domain has witnessed several technological advancements, including the adoption of controllers and automated systems. These systems not only ensure that the processes continue to run within precise limits but also make the necessary adjustments, while minimizing the risk of human errors and improving the product quality. Additionally, these controllers and automation systems have the potential to address a number of challenges associated with traditional bioprocessing systems and offer various additional benefits, such as lowering of production and labor cost (by 20-30%), optimizing the energy consumption (by 5-30%) and increasing the overall productivity (by 10-20%).
Given the various advantages of controllers and automated systems, biopharmaceutical developers and manufacturers are steadily adopting such solutions. Moreover, the recent surge in demand for vaccines amidst the ongoing COVID-19 pandemic has also prompted the biopharmaceutical companies to develop automation systems for producing drugs at a faster pace. In addition, several equipment manufacturers offering more user-friendly, controlled, and automated systems, have emerged. In fact, the field has been witnessing a lot of innovations, evident from the number of patents filed for the controllers and automation systems. These controllers and automated systems use process analytical technological tools that can be easily integrated in the bioprocessing unit to improve scalability. Stakeholders have also been focusing on making further improvements and have incorporated a variety of key features, including provisions for alerts / alarms, built-in system process control sensors, remote monitoring features, visual display, and advanced safety provisions. Owing to the rising interest of stakeholders towards technological advancement and adoption of these systems, we believe that the overall bioreactor controller and automation systems market is anticipated to witness substantial growth in the coming years.
The “Bioprocess Controllers and Automation Systems Market By Type of Controllers (Upstream / Downstream Controller System and Bioprocess Control Software), Scale of Operation (Preclinical / Clinical Operations and Commercial Operations), Mode of Operation (Batch, Fed-Batch and Perfusion), Compatibility with Bioprocessing Systems (Single-Use Systems, and Stainless Steel / Other Systems), and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030” report features an extensive study of the current landscape and the likely future potential of bioprocess controllers and automation systems, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:
One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of bioprocess controller and automation systems market. Based on multiple parameters, such as overall bioprocessing equipment market, and adoption rate of automation systems, we have provided an informed estimate of the evolution of the market for the period 2021-2030. Our year-wise projections of the current and future opportunity have further been segmented on the basis of [A] type of controllers (upstream controllers, downstream controller system and bioprocess control software), [B] scale of operation (preclinical / clinical operations and commercial operations), [C] mode of operation (batch, fed-batch and perfusion), [D] compatibility with bioprocessing systems (single-use systems, and stainless steel / other systems), and [E] key geographical regions (North America, Europe, Asia-Pacific and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
The opinions and insights presented in the report are backed by a deep understanding of key insights generated from both secondary and primary research. The information presented in this study was also influenced by discussions held with senior stakeholders in this industry.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Contents
Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of the bioprocess controller and automation systems market and its likely evolution in the short to mid-term and long term.
Chapter 3 provides a general introduction to bioprocess controller and automation systems, covering details related to the current trends in the domain. The chapter also highlights the model of process control system and its purpose. In addition, it discusses the role of automation in the process control system and the benefits and challenges related to bioprocess automation.
Chapter 4 provides a detailed assessment of the overall market landscape of upstream controllers, includes information on around 35 commercialized upstream controllers and analysis based on a number of relevant parameters, such as scale of operation (lab, clinical, and commercial), key features (scalability / ease to use, visual data display, remote accessibility, built-in system control sensors, expansive I/O compatibility and provisions for alarms / alerts), compatibility with the bioreactor systems (stirred tank (glass), single use bioreactor, stirred tank (steel), fermenter, rocking motion), mode of operation (batch, fed batch and perfusion), and type of process controlled (cell cultivation and microbial fermentation). In addition, the chapter presents details of the companies involved in the development of upstream controllers, including information on their year of establishment, company size, and location of headquarters.
Chapter 4 provides a detailed assessment of the overall market landscape of downstream controller systems, includes information on more than 50 commercialized downstream controller systems and analysis based on a number of relevant parameters, such as scale of operation (lab, clinical, and commercial), key features (scalability / ease to use, visual data display, remote accessibility, data processing capabilities, built-in system control sensors, expansive I/O compatibility and provisions for alarms / alerts), type of system(s) (single-use system and multi-use system), mode of operation (batch, fed batch and perfusion), and type of application area (therapeutic protein production, vaccine production, monoclonal antibody production, cell and gene therapy and others). In addition, it presents details of the companies involved in the development of aforementioned downstream controller systems, including information on their year of establishment, company size, and location of headquarters.
Chapter 5 provides a detailed assessment of the overall market landscape of bioprocess control software, includes information on around 35 commercialized bioprocess control software and analysis based on a number of relevant parameters, such as scale of operation (lab, clinical, and commercial), key features (scalability / ease to use, visual data display, remote accessibility, control loop, data processing capabilities and provisions for alarms / alerts), compatibility with the bioprocessing systems (stirred tank (glass), single use bioreactor, stirred tank (steel), fermenter, rocking motion, chromatography system, tangential flow filtration system), stage of bioprocess (upstream process and downstream process), and types of processes controlled (cell cultivation, microbial fermentation, chromatography and filtration). In addition, it presents details of the companies involved in the development of bioprocess control software, including information on their year of establishment, company size, and location of headquarters.
Chapter 6 features a detailed competitiveness analysis of upstream controllers, downstream controller systems and process control software, taking into consideration several relevant parameters, such as the product applicability (including, scale of operation, processes controlled, mode of operation, and stage of bioprocess) and product strength (including, key features, and compatibility with bioprocessing systems).
Chapter 7 features tabulated profiles of the key players offering upstream controllers, downstream controller systems and process control software, which are headquartered in North America. Each profile includes an overview of the company, information on financial performance (if available), details of their product portfolio, recent developments, and an informed future outlook.
Chapter 8 features tabulated profiles of the key players offering upstream controllers, downstream controller systems and process control software, which are headquartered in Europe. Each profile includes an overview of the company, information on financial performance (if available), details of their product portfolio, recent developments, and an informed future outlook.
Chapter 9 includes a contemporary market trend analysis, featuring a world map representation to highlight the regional distribution of players engaged in the development of upstream controllers, downstream controller systems and bioprocess control software, along with the information on type of products offered (upstream controllers, downstream controller systems and bioprocess control software). Further, the chapter also includes (a) a heat map representation of upstream controllers, based on compatibility with bioreactor systems, scale of operation and mode of operation, (b) a grid analysis of upstream controllers, based on scale of operation, compatibility with bioreactor systems and processes controlled (c) a grid analysis of downstream controller systems, based on scale of operation, type of systems and key features, (d) an analysis of downstream controller systems, based on mode of operation and application area (e) a grid analysis of bioprocess control software, based on by scale of operation, key features and processes controlled and (f) an analysis of bioprocess control software, based on scale of operation and compatibility with systems.
Chapter 10 provides an in-depth patent analysis presenting an overview of how the industry is evolving from the R&D perspective. For this analysis, we considered over 3,350 patents that have been filed / granted for bioprocess controller and automation systems, till July 2021, highlighting key trends associated with these patents, across type of patents, publication year, application year, issuing authorities involved, types of organizations, emerging focus area, patent age, CPC symbols, leading patent assignees (in terms of number of patents granted / filed), patent characteristics and geography. It also includes a detailed patent benchmarking and an insightful valuation analysis.
Chapter 11 features a detailed brand positioning analysis of the key industry players that are part of subsequent domain (upstream controller developers, downstream controller system developers, and bioprocess control software developers). This chapter highlights the current perceptions regarding their proprietary products by taking into consideration several relevant aspects, such as experience of the manufacturer, number of products offered, product diversity, and number of patents published.
Chapter 12 features an insightful market forecast analysis, highlighting the likely growth of the bioprocess controller and automation systems market, for the time period 2020-2030. In order to provide details on the future outlook, our year-wise projections of the current and future opportunity have further been segmented on the basis of [A] type of controllers (upstream controllers, downstream controller system and bioprocess control software), [B] scale of operation (preclinical / clinical operations and commercial operations), [C] mode of operation (batch, fed-batch and perfusion), [D] compatibility with bioprocessing systems (single-use systems (SUS), and stainless steel / other systems), and [E] key geographical regions (North America, Europe, Asia-Pacific and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
Chapter 13 is a summary of the overall report, presenting the insights on the contemporary market trends and the likely evolution of the bioprocess controller and automation systems market.
Chapter 14 contains the interview transcript(s) of the discussion held with key stakeholders engaged in this domain.
Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.
Chapter 16 is an appendix, which contains the list of companies and organizations mentioned in the report.
1. PREFACE
1.1. Overview
1.2. Scope of the Report
1.3. Key Questions Answered
1.4. Research Methodology
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Bioprocess Control
3.3. Building Block of Process Control
3.3.1. Components of Process Control Systems
3.3.1.1. Sensors
3.3.1.2. Actuators
3.3.1.3. Controllers
3.4. Purpose of Process Control
3.5. Bioprocess Automation
3.6. Advantages of Bioprocess Automation
3.7. Challenges Faced in Automated Control
3.7.1. Process Related Challenges to Automate
3.7.2. Compatibility and Infrastructure Challenges
3.7.3. Regulatory Challenges
3.7.4. IT Concerns and Data Integrity
3.8. Breakthrough in Bioprocess Control
3.8.1. Flexible and Automated Skids
3.8.2. Spectroscopy
3.8.3. Multivariate data Analytics
3.9. Future Perspective
4. MARKET LANDSCAPE: UPSTREAM CONTROLLERS
4.1. Chapter Overview
4.2. Upstream Controllers: Product Pipeline
4.2.1. Analysis by Scale of Operation
4.2.2. Analysis by Key Features
4.2.3. Analysis by Compatibility with Bioreactor System
4.2.4. Analysis by Mode of Operation
4.2.5. Analysis by Types of Processes Controlled
4.3. Upstream Controllers: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Leading Developers: Analysis by Number of Upstream Controllers
5. MARKET LANDSCAPE: DOWNSTREAM CONTROLLER SYSTEMS
5.1. Chapter Overview
5.2. Downstream Controller Systems: Product Pipeline
5.2.1. Analysis by Scale of Operation
5.2.2. Analysis by Key Features
5.2.3. Analysis by Types of Systems Involved
5.2.4. Analysis by Mode of Operation
5.2.5. Analysis by Application Area
5.3. Downstream Controller Systems: Developer Landscape
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters
5.3.4. Leading Developers: Analysis by Number of Products
6. MARKET LANDSCAPE: BIOPROCESS CONTROL SOFTWARE
6.1. Chapter Overview
6.2. Bioprocess Control Software: Product Pipeline
6.2.1. Analysis by Stage of Bioprocess
6.2.2. Analysis by Scale of Operation
6.2.3. Analysis by Key Features
6.2.4. Analysis by Compatibility with Systems
6.2.5. Analysis by Types of Processes Controlled
6.3. Bioprocess Control Software: Developer Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis of Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Leading Developers: Analysis by Number of Bioprocess Control Software
7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Methodology
7.3. Assumptions / Key Parameters
7.4. Product Competitiveness Analysis: Upstream Controllers
7.5. Product Competitiveness Analysis: Downstream Controller Systems
7.6. Product Competitiveness Analysis: Bioprocess Controller Software
8. BIOPROCESS CONTROLLER AND AUTOMATION SYSTEM DEVELOPERS IN NORTH AMERICA: COMPANY PROFILES
8.1. Chapter Overview
8.2. Cytiva Lifesciences
8.2.1. Company Overview
8.2.2. Bioprocess Controller and Automation System Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Thermo Fisher Scientific
8.3.1. Company Overview
8.3.2. Bioprocess Controller and Automation System Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. Sepragen
8.4.1. Company Overview
8.4.2. Bioprocess Controller and Automation System Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Repligen
8.5.1. Company Overview
8.5.2. Bioprocess Controller and Automation System Portfolio
8.5.3. Recent Developments and Future Outlook
9. BIOPROCESS CONTROLLER AND AUTOMATION SYSTEM DEVELOPERS IN EUROPE: COMPANY PROFILES
9.1. Chapter Overview
9.2. Applikon Biotechnology
9.2.1. Company Overview
9.2.2. Bioprocess Controller and Automation System Portfolio
9.2.3. Recent Developments and Future Outlook
9.3. Sartorius
9.3.1. Company Overview
9.3.2. Bioprocess Controller and Automation System Portfolio
9.3.3. Recent Developments and Future Outlook
9.4. Solaris Biotech
9.4.1. Company Overview
9.4.2. Bioprocess Controller and Automation System Portfolio
9.4.3. Recent Developments and Future Outlook
9.5. Sysbiotech
9.5.1. Company Overview
9.5.2. Bioprocess Controller and Automation System Portfolio
9.5.3. Recent Developments and Future Outlook
10. MARKET TREND ANALYSIS
10.1. Chapter Overview
10.2. World Map Representation: Analysis of Players by Location of Headquarters and Type of Product(s) Offered
10.3. Market Trend Analysis: Upstream Controllers
10.3.1. Heat Map Representation: Analysis by Scale of Operation, Compatibility with Bioreactor Systems and Operating Mode
10.3.2. Grid Analysis: Analysis by Scale of Operation, Compatibility with Bioreactor Systems and Types of Processes Controlled
10.4. Market Trend Analysis: Downstream Controller Systems
10.4.1. Grid Analysis: Analysis by Scale of Operation, Type of System(s) and Key Features
10.4.2. Analysis by Operation Mode and Application Area
10.5. Market Trend Analysis: Bioprocess Control Software
10.5.1. Grid Analysis: Analysis by Scale of Operation, Key Features and Types of Processes Controlled
10.5.2. Analysis by Scale of operation and Compatibility with Systems
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Bioprocess Controller and Automations Systems: Patent Analysis
11.3.1. Analysis by Publication Year
11.3.2. Analysis by Application Year
11.3.3. Analysis by Patent Office
11.3.4. Analysis by Geographical Location
11.3.5. Analysis by CPC Symbols
11.3.6. Emerging Focus Area
11.3.7. Analysis by Type of Organization
11.3.8. Leading Players: Analysis by Number of Patents
11.4. Patent Benchmarking Analysis
11.4.1. Analysis by Patent Characteristics
11.5. Bioprocess Controller and Automations Systems: Patent Valuation Analysis
11.6. Leading Patents by Number of Citations
12. BRAND POSITIONING ANALYSIS
12.1. Chapter Overview
12.2 Methodology
12.3. Key Parameters
12.4. Brand Positioning Matrix of Upstream Controller Developers
12.4.1. Brand Positioning Matrix: Applikon Biotechnology
12.4.2. Brand Positioning Matrix: Eppendorf
12.4.3. Brand Positioning Matrix: Thermo Fisher Scientific
12.4.4. Brand Positioning Matrix: ILS Automation
12.4.5. Brand Positioning Matrix: Pierre Guerin
12.5. Brand Positioning Matrix of Downstream Controller System Developers
12.5.1. Brand Positioning Matrix: Cytiva Lifesciences
12.5.2. Brand Positioning Matrix: Sepragen
12.5.3. Brand Positioning Matrix: Merck Millipore
12.5.4. Brand Positioning Matrix: Sartorius Stedim Biotech
12.5.5. Brand Positioning Matrix: Repligen
12.5.6. Brand Positioning Matrix: Agilitech
12.6. Brand Positioning Matrix of Bioprocess Controller Software Developers
12.6.1. Brand Positioning Matrix: Applikon Biotechnology
12.6.2. Brand Positioning Matrix: Pierre Guerin
12.6.3. Brand Positioning Matrix: Thermo Fisher Scientific
12.6.4. Brand Positioning Matrix: Merck Millipore
12.6.5. Brand Positioning Matrix: Sartorius Stedim Biotech
12.6.6. Brand Positioning Matrix: Cytiva Lifesciences
12.6.7. Brand Positioning Matrix: Bionet Engineering
13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Overall Bioprocess Controller and Automation Market, 2021-2030
13.4. Bioprocess Controller and Automation Market, 2021-2030: Distribution by Type of Controller
13.4.1. Bioprocess Controller and Automation Market for Upstream / Downstream Controller Systems, 2021-2030
13.4.2. Bioprocess Controller and Automation Market for Bioprocess Control Software, 2021-2030
13.5. Bioprocess Controller and Automation Market, 2021-2030: Distribution by Scale of Operation
13.5.1. Bioprocess Controller and Automation Market for Preclinical / Clinical Operations, 2021-2030
13.5.2. Bioprocess Controller and Automation Market for Commercial Operations, 2021-2030
13.6. Bioprocess Controller and Automation Market, 2021-2030: Distribution by Mode of Operation
13.6.1. Bioprocess Controller and Automation Market for Batch / Fed-batch Manufacturing, 2021-2030
13.6.2. Bioprocess Controller and Automation Market for Perfusion Manufacturing, 2021-2030
13.7. Bioprocess Controller and Automation Market, 2021-2030: Distribution by Type of Systems
13.7.1. Bioprocess Controller and Automation Market for Single-use Systems, 2021-2030
13.7.2. Bioprocess Controller and Automation Market for Stainless Steel / Other Systems, 2021-2030
13.8. Bioprocess Controller and Automation Market, 2021-2030: Distribution by Key Geographical Regions
13.8.1. Bioprocess Controller and Automation Market in North America, 2021-2030
13.8.2. Bioprocess Controller and Automation Market in Europe, 2021-2030
13.8.3. Bioprocess Controller and Automation Market in Asia-Pacific and Rest of the World, 2021-2030
14. CONCLUSION
14.1. Chapter Overview
15. EXECUTIVE INSIGHTS
16. APPENDIX 1: TABULATED DATA
17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Current Market Landscape of Upstream Controllers
Figure 2.2 Executive Summary: Current Market Landscape of Downstream Controller Systems
Figure 2.3 Executive Summary: Current Market Landscape of Bioprocess Control Software
Figure 2.4 Executive Summary: Patent Analysis
Figure 2.5 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Factors Affecting Manufacturing Process of Biologics
Figure 3.2 Overview of Controlled Parameters in Bioreactors
Figure 3.3 Basic Bioprocess Control Model
Figure 3.4 Advantages of Bioprocess Automation
Figure 4.1 Upstream Controllers: Distribution by Scale of Operation
Figure 4.2 Upstream Controllers: Distribution by Key Features
Figure 4.3 Upstream Controllers: Distribution by Compatibility with Bioreactor systems
Figure 4.4 Upstream Controllers: Distribution by Mode of Operation
Figure 4.5 Upstream Controllers: Distribution by Types of Processes Controlled
Figure 4.6 Upstream Controller Developers: Distribution by Year of Establishment
Figure 4.7 Upstream Controller Developers: Distribution by Company Size
Figure 4.8 Upstream Controller Developers: Distribution by Location of Headquarters
Figure 4.9 Leading Developers: Distribution by Number of Products
Figure 5.1 Downstream Controller Systems: Distribution by Scale of Operation
Figure 5.2 Downstream controller systems: Distribution by Key Features
Figure 5.3 Downstream Controller Systems: Distribution by Type of Bioprocessing System(s)
Figure 5.4 Downstream Controller Systems: Distribution by Mode of Operation
Figure 5.5 Downstream Controller Systems: Distribution by Application Area
Figure 5.6 Downstream Controller System Developers: Distribution by Year of Establishment
Figure 5.7 Downstream Controller System Developers: Distribution by Company Size
Figure 5.8 Downstream Controller System Developers: Distribution by Location of Headquarters
Figure 5.9 Leading Developers: Distribution by Number of Products
Figure 6.1 Bioprocess Control Software: Distribution by Stage of Bioprocess
Figure 6.2 Bioprocess Control Software: Distribution by Scale of Operation
Figure 6.3 Bioprocess Control Software: Distribution by Key Features
Figure 6.4 Bioprocess Control Software: Distribution by Compatibility with Bioprocessing Systems
Figure 6.5 Bioprocess Control Software: Distribution by Types of Processes Controlled
Figure 6.6 Bioprocess Control Software Developers: Distribution by Year of Establishment
Figure 6.7 Bioprocess Control Software Developers: Distribution by Company Size
Figure 6.8 Bioprocess Control Software Developers: Distribution by Location of Headquarters
Figure 6.9 Leading Developers: Distribution by Number of Products
Figure 7.1 Product Competitiveness Analysis: Upstream Controllers
Figure 7.2 Product Competitiveness Analysis: Downstream Controller Systems (Chromatography Systems)
Figure 7.3 Product Competitiveness Analysis: Downstream Controller Systems (Tangential Flow Filtration Systems Systems)
Figure 7.4 Product Competitiveness Analysis: Bioprocess Control Software
Figure 10.1 World Map Representation: Distribution by Location of Headquarters and Type of Product(s) Offered
Figure 10.2 Heat Map Representation: Distribution by Scale of Operation, Compatibility with Bioreactor Systems and Mode of Operation
Figure 10.3 Grid Analysis: Distribution by Upstream Controllers by Scale of Operation, Compatibility with Bioreactor Systems and Types of Processes Controlled
Figure 10.4 Grid Analysis: Distribution by Scale of Operation, Type of Bioprocessing System(s) and Key Features
Figure 10.5 Downstream Controller System: Distribution by Mode of Operation and Application Area
Figure 10.6 Grid Analysis: Distribution by Scale of Operation, Key Features and Types of Processes Controlled
Figure 10.7 Bioprocess Control Software: Distribution by Scale of Operation and Compatibility with Bioprocessing Systems
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Cumulative Distribution by Publication Year, Pre-2015-2021
Figure 11.3 Patent Analysis: Distribution by Application Year, Pre-2015-2021
Figure 11.4 Patent Analysis: Distribution by Patent Office
Figure 11.5 Patent Analysis: Distribution by Geographical Location
Figure 11.6 Patent Analysis: Distribution by CPC Symbols
Figure 11.7 Patent Analysis: Emerging Focus Areas
Figure 11.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization
Figure 11.9 Patent Analysis: Leading Industry Players
Figure 11.10 Patent Analysis: Leading Non-Industry Players
Figure 11.11 Patent Analysis: Leading Individual Assignees
Figure 11.12 Patent Analysis (Leading Industry Players): Benchmarking by Patent Characteristics (CPC Symbols)
Figure 11.13 Patent Analysis: Distribution of Patents by Age (2001-2021)
Figure 11.14 Bioprocess Controllers and Automation Systems: Patent Valuation
Figure 12.1 Brand Positioning Analysis of Upstream Controller Developers: Competitive Advantage
Figure 12.2 Brand Positioning Analysis of Upstream Controller Developers: Reasons to Believe
Figure 12.3 Brand Positioning Matrix: Applikon Biotechnology
Figure 12.4 Brand Positioning Matrix: Eppendorf
Figure 12.5 Brand Positioning Matrix: Thermo Fisher Scientific
Figure 12.6 Brand Positioning Matrix: ILS Automation
Figure 12.7 Brand Positioning Matrix: Pierre Guerin
Figure 12.8 Brand Positioning Analysis of Downstream Controller System Developers: Competitive Advantage
Figure 12.9 Brand Positioning Analysis of Downstream Controller System Developers: Reasons to Believe
Figure 12.10 Brand Positioning Matrix: Cytiva
Figure 12.11 Brand Positioning Matrix: Sepragen
Figure 12.12 Brand Positioning Matrix: Merck Millipore
Figure 12.13 Brand Positioning Matrix: Sartorius Stedim Biotech
Figure 12.14 Brand Positioning Matrix: Repligen
Figure 12.15 Brand Positioning Matrix: Agilitech
Figure 12.16 Brand Positioning Analysis of Bioprocess Control Software Developers: Competitive Advantage
Figure 12.17 Brand Positioning Analysis of Bioprocess Control Software Developers: Reasons to Believe
Figure 12.18 Brand Positioning Matrix: Applikon Biotechnology
Figure 12.19 Brand Positioning Matrix: Pierre Guérin
Figure 12.20 Brand Positioning Matrix: Thermo Fisher Scientific
Figure 12.21 Brand Positioning Matrix: Merck Millipore
Figure 12.22 Brand Positioning Matrix: Sartorius Stedim Biotech
Figure 12.23 Brand Positioning Matrix: Cytiva
Figure 12.24 Brand Positioning Matrix: Bionet Engineering
Figure 13.1 Overall Bioprocess Controllers and Automation Systems Market, 2021-2030 (USD Million)
Figure 13.2 Bioprocess Controller and Automation Market, 2021-2030: Distribution by Type of Controller (USD Million)
Figure 13.3 Bioprocess Controller and Automation Market for Upstream / Downstream Controller Systems, 2021-2030 (USD Million)
Figure 13.4 Bioprocess Controller and Automation Market for Bioprocess Control Software, 2021-2030 (USD Million)
Figure 13.5 Bioprocess Controller and Automation Market, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 13.6 Bioprocess Controller and Automation Market for Preclinical / Clinical Operations, 2021-2030 (USD Million)
Figure 13.7 Bioprocess Controller and Automation Market for Commercial Operations, 2021-2030 (USD Million)
Figure 13.8 Bioprocess Controller and Automation Market, 2021-2030: Distribution by Mode of Operation (USD Million)
Figure 13.9 Bioprocess Controller and Automation Market for Batch / Fed-batch Manufacturing, 2021-2030 (USD Million)
Figure 13.10 Bioprocess Controller and Automation Market for Perfusion Manufacturing, 2021-2030 (USD Million)
Figure 13.11 Bioprocess Controller and Automation Market, 2021-2030: Distribution by Type of Bioprocessing Systems (USD Million)
Figure 13.12 Bioprocess Controller and Automation Market for Single-use Systems, 2021-2030 (USD Million)
Figure 13.13 Bioprocess Controller and Automation Market for Stainless Steel / Other Systems, 2021-2030 (USD Million)
Figure 13.14 Bioprocess Controller and Automation Market, 2021-2030: Distribution by Key Geographical Regions (USD Million)
Figure 13.15 Bioprocess Controller and Automation Market in North America, 2021-2030 (USD Million)
Figure 13.16 d (USD Million)
Figure 13.17 Bioprocess Controller and Automation Market in Asia-Pacific and Rest of the World, 2021-2030 (USD Million)
Figure 14.1 Concluding Remarks: Current Market Landscape of Upstream Controllers
Figure 14.2 Concluding Remarks: Current Market Landscape of Downstream Controller Systems
Figure 14.3 Concluding Remarks: Current Market Landscape of Bioprocess Control Software
Figure 14.4 Concluding Remarks: Patent Analysis
Figure 14.5 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 4.1 Upstream Controllers: Information on Dimensions and Scale of Operation
Table 4.2 Upstream Controllers: Information on Key Features, Mode of Operation, Compatibility with Bioreactor Systems and Types of Processes Controlled
Table 4.3 Upstream Controller Developers: Information of Year of Establishment, Company Size and Location of Headquarters
Table 5.1 Downstream Controller Systems: Information on Dimensions, Type of Controllers and Scale of Operation
Table 5.2 Downstream Controller Systems: Information on Key Features, Type of Bioprocessing System(s) Involved, Mode of Operation and Application Area
Table 5.3 Downstream Controller System Developers: Information of Year of Establishment, Company Size and Location of Headquarters
Table 6.1 Bioprocess Control Software: Information on Stage of Bioprocess and Scale of Operation
Table 6.2 Bioprocess Control Software: Information on Key Features, Compatibility with Bioprocessing Systems and Types of Processes Controlled
Table 6.3 Bioprocess Control Software Developers: Information of Year of Establishment, Company Size and Location of Headquarters
Table 8.1 Bioprocess Controllers and Automation: List of Companies Profiled
Table 8.2 Cytiva Lifesciences: Company Snapshot
Table 8.3 Cytiva Lifesciences: Product Portfolio (Downstream Controller Systems)
Table 8.4 Cytiva Lifesciences: Product Portfolio (Bioprocess Control Software)
Table 8.5 Cytiva Lifesciences: Recent Developments and Future Outlook
Table 8.6 Thermo Fisher Scientific: Company Snapshot
Table 8.7 Thermo Fisher Scientific: Product Portfolio (Upstream Controllers)
Table 8.8 Thermo Fisher Scientific: Product Portfolio (Bioprocess Control Software)
Table 8.9 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 8.10 Sepragen: Company Snapshot
Table 8.11 Sepragen: Product Portfolio (Downstream Controller Systems)
Table 8.12 Repligen Corporation: Company Snapshot
Table 8.13 Repligen: Product Portfolio (Downstream Controller Systems)
Table 8.14 Repligen Corporation: Recent Developments and Future Outlook
Table 9.1 Bioprocess Controllers and Automation: List of Companies Profiled
Table 9.2 Applikon Biotechnology: Company Snapshot
Table 9.3 Applikon Biotechnology: Product Portfolio (Upstream Controllers)
Table 9.4 Applikon Biotechnology: Product Portfolio (Bioprocess Control Software)
Table 9.5 Applikon biotechnology: Recent Developments and Future Outlook
Table 9.6 Sartorius: Company Snapshot
Table 9.7 Sartorius: Product Portfolio (Upstream Controllers)
Table 9.8 Sartorius: Product Portfolio (Downstream Controller Systems)
Table 9.9 Sartorius: Product Portfolio (Bioprocess Control Software)
Table 9.10 Sartorius: Recent Developments and Future Outlook
Table 9.11 Solaris Biotech: Company Snapshot
Table 9.12 Solaris Biotech: Product Portfolio (Upstream Controllers)
Table 9.13 Solaris Biotech: Product Portfolio (Downstream Controller Systems)
Table 9.14 Solaris Biotech: Product Portfolio (Bioprocess Control Software)
Table 9.15 Solaris Biotech: Recent Developments and Future Outlook
Table 9.16 Sysbiotech: Company Snapshot
Table 9.17 Sysbiotech: Product Portfolio (Upstream Controllers)
Table 9.18 Sysbiotech: Recent Developments and Future Outlook
Table 11.1 Patent Analysis: Prominent CPC Symbols
Table 11.2 Patent Analysis: List of Top CPC Symbols
Table 11.3 Patent Analysis: Leading CPC Symbol Definitions
Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 16.1 Upstream Controllers: Distribution by Scale of Operation
Table 16.2 Upstream Controllers: Distribution by Key Features
Table 16.3 Upstream Controllers: Distribution by Compatibility with Bioreactor systems
Table 16.4 Upstream Controllers: Distribution by Mode of Operation
Table 16.5 Upstream Controllers: Distribution by Types of Processes Controlled
Table 16.6 Upstream Controller Developers: Distribution by Year of Establishment
Table 16.7 Upstream Controller Developers: Distribution by Company Size
Table 16.8 Upstream Controller Developers: Distribution by Location of Headquarters
Table 16.9 Leading Developers: Distribution by Number of Products
Table 16.10 Downstream Controller Systems: Distribution by Scale of Operation
Table 16.11 Downstream Controller Systems: Distribution by Key Features
Table 16.12 Downstream Controller Systems: Distribution by Type of Bioprocessing System(s)
Table 16.13 Downstream Controller Systems: Distribution by Mode of Operation
Table 16.14 Downstream Controller Systems: Distribution by Application Area
Table 16.15 Downstream Controller System Developers: Distribution by Year of Establishment
Table 16.16 Downstream Controller System Developers: Distribution by Company Size
Table 16.17 Downstream Controller System Developers: Distribution by Location of Headquarters
Table 16.18 Leading Developers: Distribution by Number of Products
Table 16.19 Bioprocess Control Software: Distribution by Stage of Bioprocess
Table 16.20 Bioprocess Control Software: Distribution by Scale of Operation
Table 16.21 Bioprocess Control Software: Distribution by Key Features
Table 16.22 Bioprocess Control Software: Distribution by Compatibility with Bioprocessing Systems
Table 16.23 Bioprocess Control Software: Distribution by Types of Processes Controlled
Table 16.24 Bioprocess Control Software Developers: Distribution by Year of Establishment
Table 16.25 Bioprocess Control Software Developers: Distribution by Company Size
Table 16.26 Bioprocess Control Software Developers: Distribution by Location of Headquarters
Table 16.27 Leading Developers: Distribution by Number of Products
Table 16.28 Downstream Controller System: Distribution by Operating Mode and Application Area
Table 16.29 Bioprocess Control Software: Distribution by Scale of Operation and Compatibility with Systems
Table 16.30 Patent Analysis: Distribution by Type of Patent
Table 16.31 Patent Analysis: Cumulative Distribution by Publication Year, Pre-2015-2021
Table 16.32 Patent Analysis: Distribution by Application Year, Pre-2015-2021
Table 16.33 Patent Analysis: Distribution by Patent Office
Table 16.34 Patent Analysis: Distribution by Geographical Location
Table 16.35 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization
Table 16.36 Patent Analysis: Leading Industry Players
Table 16.37 Patent Analysis: Leading Non-Industry Players
Table 16.38 Patent Analysis: Leading Individual Assignees
Table 16.39 Patent Analysis: Distribution of Patents by Age (2001-2021)
Table 16.40 Bioprocess Controllers and Automation Systems: Patent Valuation
Table 16.41 Overall Bioprocess Controllers and Automation Systems Market, 2021-2030 (USD Million)
Table 16.42 Bioprocess Controller and Automation Market, 2021-2030: Distribution by Type of Controller (USD Million)
Table 16.43 Bioprocess Controller and Automation Market for Upstream / Downstream Controller Systems, 2021-2030 (USD Million)
Table 16.44 Bioprocess Controller and Automation Market for Bioprocess Control Software, 2021-2030 (USD Million)
Table 16.45 Bioprocess Controller and Automation Market, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 16.46 Bioprocess Controller and Automation Market for Preclinical / Clinical Operations, 2021-2030 (USD Million)
Table 16.47 Bioprocess Controller and Automation Market for Commercial Operations, 2021-2030 (USD Million)
Table 16.48 Bioprocess Controller and Automation Market, 2021-2030: Distribution by Mode of Operation (USD Million)
Table 16.49 Bioprocess Controller and Automation Market for Batch / Fed-batch Manufacturing, 2021-2030 (USD Million)
Table 16.50 Bioprocess Controller and Automation Market for Perfusion Manufacturing, 2021-2030 (USD Million)
Table 16.51 Bioprocess Controller and Automation Market, 2021-2030: Distribution by Type of Bioprocessing Systems (USD Million)
Table 16.52 Bioprocess Controller and Automation Market for Single-use Systems, 2021-2030 (USD Million)
Table 16.53 Bioprocess Controller and Automation Market for Stainless Steel / Other Systems, 2021-2030 (USD Million)
Table 16.54 Bioprocess Controller and Automation Market, 2021-2030: Distribution by Key Geographical Regions (USD Million)
Table 16.55 Bioprocess Controller and Automation Market in North America, 2021-2030 (USD Million)
Table 16.56 Bioprocess Controller and Automation Market in Europe, 2021-2030 (USD Million)
Table 16.57 Bioprocess Controller and Automation Market in Asia-Pacific and Rest of the World, 2021-2030 (USD Million)
The following companies and organizations have been mentioned in the report.
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
YOU MAY ALSO LIKE
SUBSCRIBE TO INDUSTRY UPDATES